Anonymous
Guest
Anonymous
Guest
AbbVie will utilize the manufacturing operations of Abbott to source it's drugs, information released today.
"The size of the contract manufacturing operations is not broken out in the prospectus, although a report on Outsourcing-Pharma estimates it could make around $420 million a year.
AbbVie's contract manufacturing business will sign "one or more manufacturing and supply agreements with Abbott" as part of the separation process, and will ‘manufacture, label and package’ products for its sibling.
The manufacturing and supply agreements will have a term of up to five years, and payments will be determined on ‘an arm's length basis’, according to the filing."
http://www.inpharm.com/news/172969/abbott-sets-out-abbvie-stall-shareholders
Real news pushing the stupid stuff off page 1, so you stay informed.
"The size of the contract manufacturing operations is not broken out in the prospectus, although a report on Outsourcing-Pharma estimates it could make around $420 million a year.
AbbVie's contract manufacturing business will sign "one or more manufacturing and supply agreements with Abbott" as part of the separation process, and will ‘manufacture, label and package’ products for its sibling.
The manufacturing and supply agreements will have a term of up to five years, and payments will be determined on ‘an arm's length basis’, according to the filing."
http://www.inpharm.com/news/172969/abbott-sets-out-abbvie-stall-shareholders
Real news pushing the stupid stuff off page 1, so you stay informed.